Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy

Assiut University50 enrolled

Overview

The aim of this work to evaluate the accuracy of contrast enhanced spectral mamography in predicting the response to NAC and assessment of residual disease in breast cancer patients

This a prospective series ,will be performed for 50 patients diagnosed by biopsy as breast cancer who will be scheduled for surgery after completing the full coarse of neoadjuvant chemotherapy

Study Type

OBSERVATIONAL

Enrollment

Conditions

Breast Cancer

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * patient confirmed diagnosed by early breast cancer decided to received neoadjuvant treatment * locally advanced breast cancer * operable metastatic breast cancer Exclusion Criteria: * patient not candidate for NAC * contrast allergy * renal impairment * pregnancy

Outcomes

Primary Outcomes

Accuracy of contrast enhanced spectral mamography in the predicting of pathological response to NAC and assessment residual disease in breast cancer patients

Time frame: Basline

Secondary Outcomes

Assess best imaging modalities in pedict post neoadjuvant response

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.